Harbour Investments’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-100
Closed -$4.21K 3135
2023
Q2
$4.21K Hold
100
﹤0.01% 2336
2023
Q1
$3.56K Hold
100
﹤0.01% 2400
2022
Q4
$3.67K Sell
100
-700
-88% -$27.7K ﹤0.01% 2330
2022
Q3
$57K Hold
800
﹤0.01% 1219
2022
Q2
$57K Buy
+800
New +$58.5K ﹤0.01% 1219
2021
Q4
$65K Hold
630
﹤0.01% 1146
2021
Q3
$55K Buy
630
+413
+190% +$37.4K ﹤0.01% 1716
2021
Q2
$19K Buy
217
+107
+97% +$9.04K ﹤0.01% 2378
2021
Q1
$8K Buy
+110
New +$8.29K ﹤0.01% 2736

Other funds holding SYNH

Harbour Investments's SYNH Position: Q3 2023 in Review

Harbour Investments sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 100 shares — an estimated $4.21K sold.

Harbour Investments first reported a position in SYNH in Q1 2021 and held it in 9 quarters. The position peaked at $65K in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Harbour Investments reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Harbour Investments sold 100 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $4.21K.
  • Harbour Investments first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2021 and held it in 9 quarters.
  • Harbour Investments's Syneos Health, Inc. Class A Common Stock position peaked at $65K in Q4 2021.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Harbour Investments's 13F filing for Q3 2023, filed 15 Nov 2023.